Alabama’s Cannabis Landscape Flourishes as Licenses Find Renewal
In a pivotal move that has set Alabama’s medical cannabis industry on a new trajectory, the Alabama Medical Cannabis Commission (AMCC) has recently re-awarded licenses for the production and distribution of medical cannabis. The decision, prompted by questions surrounding application evaluations that had halted the process in June, marks a significant turning point in the state’s cannabis journey.
The licenses, nearly all of which were previously granted two months ago, have been returned to their rightful holders. However, the commission’s latest move also includes the issuance of additional licenses, specifically aimed at enabling further growth in the medical cannabis sector. Rex Vaughn, the newly elected chair of the commission, delivered a promising message to those who had previously been denied licenses. He hinted that the commission might be open to considering new applications in the future, once the impact of the current licenses becomes more apparent.
Vaughn reassured, “We will undergo a comprehensive reevaluation and investigative process to assess our current position. So, for those who were not granted licenses today, there’s still hope. Another opportunity may await.”
While most of the license awardees from the initial round have been reinstated, Chicago-based Verano faced an exception. The commission made a decision not to disclose the reason behind Verano’s application denial. Furthermore, the commission expanded the quota of cultivator licenses from four to seven, indicating a renewed commitment to nurturing the cannabis cultivation sector.
In its authority, the commission is empowered to grant up to twelve licenses for cannabis cultivation, four for processing, and an additional four for product dispensation. Additionally, there’s a provision for up to five licenses for integrated facilities that encompass cultivation, processing, and distribution of medical cannabis.
This latest development puts an end to a two-month-long period of uncertainty surrounding the licenses, a time fraught with concerns about the fairness and transparency of the application scoring process. Soon after the initial license announcements, the commission swiftly imposed a temporary halt on the licensing procedure, citing “scoring inconsistencies” that had the potential for dire consequences had the licenses been issued prematurely.
The University of South Alabama, brought in as evaluators, unearthed the root cause of these issues. Lynne Chronister, the university’s vice president for research and economic development, and Kristen Roberts, the financial officer, addressed the commission. They outlined a series of human errors that had tainted the process.
One such error involved an evaluator mistakenly inputting a score for an integrated facility application twice, leading to inaccuracies in the scores of applications falling beneath this duplicate score. Roberts explained, “As we were summing and averaging those applicants’ scores, it was picking up the wrong two numbers.”
Chronister and Roberts also highlighted other errors in data entry, incorrect weight applications to scores, flawed score averaging by evaluators, and a mismatch in the scores used by the university evaluators for assessing written applications.
Roberts underscored the university’s diligence in rectifying these variances and emphasized, “We have complete confidence in the dataset we’ve presented to the Commission. These corrections have been independently verified by KPMG.”
The commission made a conscious effort to enhance transparency during the recent hearing. Prior to entering into an executive session, the commission’s legal representative, William Webster, detailed the agenda for the closed session and the method for selecting nominated companies eligible for a public vote.
Webster directed each commission member to individually nominate companies for each category, ensuring that only those nominated companies would be subjected to a public vote during the open session. Vaughn, reiterating the commission’s authority, stressed that their primary role in decision-making remained intact, independent of third-party evaluations and recommendations.
Vaughn clarified, “This means that the commission retains the discretion to align with these evaluations and suggestions.”
He also disclosed that commission members had received the recalculated scores over a week ago and had the chance to discuss sensitive matters during the executive session. These discussions pertained to the professional services provided by the University of South Alabama.
The catalyst for this entire situation traces back to the Alabama Legislature’s approval of a medical cannabis program in 2021. However, the authorization bill stipulated that licenses could not be issued until September 1, 2022. The AMCC started accepting applications towards the end of the previous year.
Upon availability, individuals certified by designated physicians will gain access to medical cannabis for treating fifteen different conditions, encompassing cancer, chronic pain, depression, and Parkinson’s Disease. Patients will need to acquire a card to make purchases from licensed dispensaries.
The law, however, prohibits smoking or consumption of medical cannabis through food. The product will be available in various forms like tablets, capsules, oils, creams, and more. Interestingly, cannabis gummies will be exclusively limited to a peach flavor.
The application process saw keen interest, with 38 entities vying for integrated facility licenses, another 12 seeking cultivator licenses, 12 applying for processor licenses, and 18 competing for dispensary licenses. Additionally, the commission received applications for transport and testing licenses, exact counts of which remain unknown.
As Alabama’s medical cannabis sector charts its course forward, the reissuance of licenses breathes new life into the industry, fostering growth and innovation.
